bpc-157 fda status warning unapproved drug peptide safety advisory committee votes to add popular to compounding list Peptide Compounding Vote Raises New – bpc-157 fda approval status warning

The vial math below assumes a 5 mg vial reconstituted with 2.0 mL BAC water (2.5 mg/mL) for the 2.4 mg/week target

SLU-PP-332 Reconstitution: Vial Mixing & Oral Cap Notes Ion's 30 mg vial is the only injectable path

BPC-157 is still in experimental stages in veterinary medicine, and is not recognized as a standard approved treatment to dogs

USP Monograph Compliance The 0.9% benzyl alcohol concentration matches the USP bacteriostatic water for injection monograph, the reference specification used in research and clinical supply contexts

Deficiency with malabsorption/pernicious anemia: follow loading + maintenance injections

Our dedicated team will discuss any associated costs clearly before administering your B12 injection, including clarification of consultation fees and any potential insurance coverage